Network origin in Dean Eliott first degree
Entity | Entity type | Industry | |
---|---|---|---|
Helio Vision, Inc.
Helio Vision, Inc. Pharmaceuticals: MajorHealth Technology Helio Vision, Inc. operates as a biotechnology company. It develops a therapy for fibroproliferative disorders that lead to abnormal scarring and blindness after retina surgery. The company was founded by Josef H. von Rickenbach, Dean Eliott and Tomasz P. Stryjewski in 2016 and is headquartered in Waltham, MA.
10
| Subsidiary | Pharmaceuticals: Major | 10 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Dean Eliott via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
ALDEYRA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer Chairman Director/Board Member | |
Domain Associates LLC
Domain Associates LLC Investment ManagersFinance Domain Associates LLC (Domain Associates) is a venture capital firm founded in 1985. The firm is headquartered in Princeton, New Jersey. | Investment Managers | Private Equity Investor Private Equity Investor | |
IOMAI CORPORATION | Biotechnology | Director/Board Member Director/Board Member | |
PAREXEL INTERNATIONAL CORPORATION | Miscellaneous Commercial Services | Chief Executive Officer | |
Boston University | College/University | Doctorate Degree | |
eXIthera Pharmaceuticals, Inc.
eXIthera Pharmaceuticals, Inc. BiotechnologyHealth Technology eXIthera Pharmaceuticals, Inc. develops and manufactures stroke prevention and antithrombosis drugs. Its drugs are based on the pathophysiological role of Factor XI in the initiation of intravascular thrombi without causing undue bleeding. The firm’s drug candidates are small, orally active, and highly selective Factor XI inhibitors. The company was founded by Neil J. Hayward and Frans L. Stassen in 2012 and is headquartered in Westborough, MA. | Biotechnology | Director/Board Member | |
Cold Spring Venture Advisors LLC
Cold Spring Venture Advisors LLC Investment ManagersFinance Cold Spring Venture Advisors LLC provides investment management services. The private company is based in Newton, MA. | Investment Managers | Corporate Officer/Principal | |
Cleveland Diagnostics, Inc.
Cleveland Diagnostics, Inc. Investment Trusts/Mutual FundsMiscellaneous Cleveland Diagnostics, Inc. develops and commercializes cancer diagnostics and screening tests. Its portfolio of non-invasive cancer diagnostic tests includes blood-based tests to screen for prostate, breast, and ovarian cancer. The company was founded by Arnon Chait and Boris Zaslavsky in October 2013 and is headquartered in Cleveland, OH. | Investment Trusts/Mutual Funds | Chairman | |
OPKO HEALTH, INC. | Medical/Nursing Services | Founder | |
BioSurface Technology, Inc.
BioSurface Technology, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sanofi, BioSurface Technology, Inc. is a commercial biotechnical research company. The company is based in Cambridge, MA. The company was founded by David L. Castaldi, Ben R. Bronstein. BioSurface Technology was acquired by Genzyme Corp., part of Sanofi from April 08, 2011 on December 16, 1994. | Miscellaneous Commercial Services | Founder | |
ACLARIS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
STEALTH BIOTHERAPEUTICS CORP | Biotechnology | Chief Tech/Sci/R&D Officer | |
Sentien Biotechnologies, Inc.
Sentien Biotechnologies, Inc. BiotechnologyHealth Technology Sentien Biotechnologies, Inc. develops cell-based therapy for critical care. It provides the Sentinel, a device that actively treats patients during a dialysis dose by supplementing patient blood with MSC-derived secretions. The company was founded by Brian Miller and Biju Parekkadan and is headquartered in Lexington, MA. | Biotechnology | Corporate Officer/Principal | |
CardioPolymers, Inc.
CardioPolymers, Inc. Pharmaceuticals: MajorHealth Technology CardioPolymers, Inc. provides novel biocompatible polymer implant therapies to treat cronic heart failures. The company was founded in 2003 and is headquartered in Laguna Hills, CA. | Pharmaceuticals: Major | Director/Board Member | |
Dartmouth College | College/University | Undergraduate Degree | |
Vidus Ocular, Inc.
Vidus Ocular, Inc. Medical SpecialtiesHealth Technology Part of OPKO Health, Inc., Vidus Ocular, Inc. is a company that manufactures shunts to treat glaucoma. The company is based in New Haven, CT. Vidus Ocular was acquired by OPKO Health, Inc. on May 07, 2008 for $2.71 million. The company was founded by James R. McNab, Ben R. Bronstein. | Medical Specialties | Founder | |
NovaDigm Therapeutics, Inc.
NovaDigm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology NovaDigm Therapeutics, Inc. developes innovative immunotherapeutics and preventative vaccines. It protect patients from fungal and bacterial infections, which can be recurrent, drug-resistant and in some cases, life-threatening. The firm NDV-3A, is the first vaccine to demonstrate preclinical efficacy in reducing the severity of disease caused by both fungal and bacterial pathogens. NDV-3A is in Phase 2 clinical development for recurrent vulvovaginal candidiasis (RVVC) with follow-on indications planned for Candida, a fungal pathogen, and Staphylococcus aureus, including MRSA. The company was founded by Toumas R. Holmberg, Michael R. Yeaman, Frederick M.Haneyand John E. Eswards Jr. in 2005 and is headquartered in Grand Forks ND. | Pharmaceuticals: Major | Director/Board Member | |
Echelon Ventures
Echelon Ventures Investment ManagersFinance Echelon Ventures (Echelon Ventures) is a venture capital firm founded in 2000 by Woody S Woodworth and Scott C McCabe. The firm is headquartered in Waltham, Massachusetts. | Investment Managers | Private Equity Investor | |
Penn Medicine Princeton Health
Penn Medicine Princeton Health Hospital/Nursing ManagementHealth Services Penn Medicine Princeton Health provides health care services. It serves the lifelong needs of central New Jersey residents, including acute care hospital services through University Medical Center of Princeton, behavioral healthcare through Princeton House Behavioral Health, rehabilitation, home care, hospice care, ambulatory surgery, a medical practice, and fitness and wellness services. The company was founded in 1978 and is headquartered in Plainsboro, NJ. | Hospital/Nursing Management | Director/Board Member | |
Technicon Instruments Corp. | Corporate Officer/Principal | ||
GE AEROSPACE | Industrial Machinery | Corporate Officer/Principal | |
Xagenic, Inc.
Xagenic, Inc. Medical SpecialtiesHealth Technology Xagenic, Inc. develops the first lab-free molecular diagnostic platform. Its automated diagnostic platform will enable widespread decentralized testing to be performed outside of clinical laboratories. The firm's amplified redox assay detection technology utilizes electrochemical detection methods and does not rely on optical detection components or enzymatic amplification; crude samples can be analyzed with minimal sample processing. The company was founded by Shana O. Kelley and Edward Hartley Sargent in 2010 and is headquartered in Toronto, Canada. | Medical Specialties | Director/Board Member | |
RightCare Solutions, Inc.
RightCare Solutions, Inc. Packaged SoftwareTechnology Services Right Care Solutions, Inc. develops a discharge decision support platform. It offers risk assessment by flagging patients at risk for readmissions when admitted to the hospital. The solution also provides recommendations regarding post-acute care and community-based services for patients. The company was founded by Eric M. Heil and Kathyrn H. Bowles in 2011 and is headquartered in Horsham, PA. | Packaged Software | Director/Board Member | |
One Palmer Square Associates VIII LLC | Corporate Officer/Principal | ||
Alere San Diego, Inc.
Alere San Diego, Inc. Medical SpecialtiesHealth Technology Alere San Diego, Inc. develops, manufactures, and markets, diagnostic products. The company was founded by Kim D. Blickenstaff and Gunars E. Valkirs on June 28, 1988 and is headquartered in San Diego, CA. | Medical Specialties | Director/Board Member | |
VERACYTE, INC. | Medical Specialties | Director/Board Member | |
COLUCID PHARMACEUTICALS INC | Biotechnology | Director/Board Member | |
Afferent Pharmaceuticals, Inc.
Afferent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Afferent Pharmaceuticals, Inc. develops selective drugs for the treatment of debilitating neurogenic disorders. It offers programs for respiratory, cardiovascular, chronic pain, biology, and clinical trials. The firm offers drugs for osteoarthritis pain, treatment-refractory chronic cough, and interstitial cystitis or bladder pain syndrome. The company was founded by Anthony P. Ford in December 2009 and is headquartered in San Mateo, CA. | Pharmaceuticals: Major | Director/Board Member | |
EVOKE PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
ADERIS Pharmaceuticals, Inc.
ADERIS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ADERIS Pharmaceuticals, Inc. develops and commercializes drugs and pharmaceuticals. It engages in small molecule drug development to treat central nervous system, cardiovascular, and inflammatory disorders. The company was founded by Donald McAfee, Noel Cusack, Gevork I. Minaskanian, and Peter Savasand in 1994 and is headquartered in Hopkinton, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Phenome Sciences, Inc. | Chief Executive Officer | ||
MAXCYTE, INC. | Biotechnology | Chairman | |
BioTheryX, Inc.
BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY. | Pharmaceuticals: Major | Chairman | |
Miller-Rich Associates LLC | Chief Executive Officer | ||
TEN63 Therapeutics
TEN63 Therapeutics Pharmaceuticals: MajorHealth Technology TEN63 Therapeutics provides drug development services. The American company was founded by Nancy Miller-Rich, Marcel Frenkel, Mark Hallen, Bruce Donald. Marcel Frenkel has been the CEO since incorporation. | Pharmaceuticals: Major | Founder | |
4D MOLECULAR THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Attralus, Inc.
Attralus, Inc. Pharmaceuticals: MajorHealth Technology Attralus, Inc. operates as a biopharmaceutical company. The firm focuses on illuminating the systemic nature of amyloidosis and creating transformative medicines to improve the lives of patients. The company was founded by Jonathan Wall in 2019 and is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member | |
KADMON HOLDINGS, INC. | Biotechnology | Director/Board Member | |
Altum Pharmaceuticals, Inc.
Altum Pharmaceuticals, Inc. Pharmaceuticals: GenericHealth Technology Altum Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the clinical and commercial development of novel healthcare products for the treatment of women's gynecological neoplasia, autoimmune disorders, Hypercalcemia of Malignancy, Skeletal Related Events and Osteoporosis diseases. The company was founded in 2016 and is headquartered in Vancouver, Canada. | Pharmaceuticals: Generic | Chairman | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Ithaca College | College/University | Undergraduate Degree | |
Global Alliance for TB Drug Development
Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | Pharmaceuticals: Generic | Director/Board Member | |
UDG HEALTHCARE PLC | Miscellaneous Commercial Services | Director/Board Member | |
Labyrinth Choir, Inc. | Director/Board Member |
Statistics
International
United States | 47 |
Canada | 3 |
Israel | 2 |
Ireland | 2 |
Sectoral
Health Technology | 30 |
Finance | 6 |
Commercial Services | 4 |
Consumer Services | 4 |
Health Services | 3 |
Operational
Director/Board Member | 79 |
Corporate Officer/Principal | 27 |
Independent Dir/Board Member | 24 |
Founder | 12 |
Chairman | 11 |
Most connected contacts
Insiders | |
---|---|
Jesse I. Treu | 38 |
Gary Phillips | 20 |
Todd Brady | 20 |
Josef H. Von Rickenbach | 19 |
Ben Bronstein | 16 |
Nancy Miller-Rich | 15 |
Martin Joyce | 10 |
Richard Douglas | 10 |
Tomasz P. Stryjewski | 2 |
Neil Walker | 1 |
- Stock Market
- Insiders
- Dean Eliott
- Company connections